Zoom-Zoom+Black contrastBlue contrastWhite contrast

English

How to use the speech recognition tool?

LithuanianLithuania

 

Update: 10.06.2020

 

Health Care Provider Name: Hospital of Lithuanian University of Health Sciences Kauno klinikos.

Contact Name: Dr Arvydas Gelzinis, head of Rare eye disease center.

 

 

 

 

Professional

Usual Rare Eye Diseases

consultations

Consultations are opened, but to a lesser extent.

Picto Helpdesk

If closed, teleconsultations

access

We have distant consultations by phone. However, we consult family doctors, not the patients. Patients can contact us using official emails.

More information

Retinal

Intra-vitreal therapies

(i.e.anti VEGF)

I/v injections are maintained on a degraded mode, but their number has increased since April and May.

Teleconsultation

Eye emergencies link for

RED complications

Eye emergencies are continued. All conditions, whose delay might cause avoidable blindness, are treated (congenital cataract, decompensated glaucoma, ROP laser, etc.)

Genetics

Genetic testing for RED:

maintained/discontinued

At the moment we restart genetic counselling for rare eye diseases.

Guidelines

specific COVID guidelines from

your GOVERNMENT/TOWN/ REGION

for poorly sighted patients

(or disabled persons or persons with rare diseases)

No.

Guidelines

specific COVID guidelines from the

PATIENT GROUPS/ASSOCIATIONS

for Poorly sighted/Blind patients

(or disabled persons or persons with rare diseases)

No.

 

Guidelines

specific COVID guidelines from LEARNED NATIONAL/REGIONAL SOCIETIES

for ophthalmic diseases care, poorly sighted patients

(or disabled persons or persons with rare diseases)

and rare eye diseases

No.

 

Clinical trials for RED:

  • inclusions ongoing/postponed

  • follow up visits: done on time/ delayed

  • Are patients under trial with COVID identified as having an adverse effect Yes/No

  • Industry cope? Yes/No

We do not have clinical trials for RED.

 

 

Link to the website of the Ministery of Health in Lithuania

 

 

 

Subscribe to our mailing list

* indicates required

This ERN is supported by: